Amyl Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Liege
Industry:BiotechHealth services
Business model:B2B
Amyl Therapeutics is a preclinical stage biotechnology company in Belgium
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.62M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Amyl Therapeutics
Name | Criteria | |
---|---|---|
![]() |
iLoF
60%
|
|
![]() |
Monocl
60%
|
|
![]() |
Octarine Bio
60%
|
|
![]() |
Veritas Intercontinental
60%
|
|
![]() |
PEP-Therapy
60%
|
|
![]() |
DeepLife
60%
|
|
![]() |
Biorelate
60%
|
|
![]() |
OxCan
60%
|
|
![]() |
Multiomic Health
60%
|
|
![]() |
Cellply
60%
|
|